Fresh Equities
BIONOMICS LIMITED

BIONOMICS LIMITED

ASX:BNO

Last Placement
Bidding Closed
Offer Price
Not Available
Discount to Close
Not Available
Raised
$9.84M
Last Close
$0.1550
Market Cap at Close
Not Available
Relisted
Nov 13, 2018

Company Information

Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Type

Listed Company

GICS Sub-Industry

Biotechnology

Head Office

31 Dalgleish St, Thebarton SA 5031, Australia

Biotechnology
Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.



Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Archive
Support
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.